Atlas Capital Advisors LLC Gsk PLC Transaction History

Atlas Capital Advisors LLC

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 16, 2022	SELL	$42.05 - $47.77 $639,370 - $726,342	-15,205 Closed	0 $0
Q1 2022 May 11, 2022	BUY	$40.23 - $47.74 $6,316 - $7,495	157 Added 1.04%	15,205 $662 Million
Q4 2021 Feb 01, 2022	BUY	$38.88 - $45.31 $575,151 - $670,270	14,793 Added 5801.18%	15,048 $664 Million
Q3 2021 Oct 28, 2021	BUY	$38.79 - $43.16 $9,891 - $11,005	255 New	255 $9,000
Q1 2021 May 10, 2021	SELL	$34.27 - $40.01 $58,807 - $68,657	-1,716 Closed	0 $0
Q4 2020 Feb 16, 2021	BUY	$34.07 - $39.94 $58,464 - $68,537	1,716 New	1,716 $64,000
Q2 2020 Jul 28, 2020	SELL	$37.87 - $43.58 $6,551 - $7,539	-173 Closed	0 $0
Q1 2020 May 04, 2020	BUY	$32.47 - $48.83 $5,617 - $8,447	173 New	173 $6,000
Q3 2019 Nov 01, 2019	SELL	$40.46 - $43.52 $800,339 - $860,869	-19,781 Closed	0 $0
Q2 2019 Jul 25, 2019	BUY	$39.4 - $42.7 $572,718 - $620,687	14,536 Added 277.14%	19,781 $0
Q4 2018 Jan 29, 2019	BUY	$37.8 - $42.69 $198,260 - $223,909	5,245 New	5,245 $204,000

176K

Ticker GSK
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,033,689,984
Market Cap $68.3B
Description
GSK plc, together with its subsidiaries, engages in the creation, discovery, development, manufacture, and marketing of pharmaceutical products, vaccines, over-the-counter medicines, and health-related consumer products in the United Kingdom, the United States, and internationally. It operates through four segments: Pharmaceuticals, Pharmaceutic...

Get notified when there are updates to the investment portfolio of Atlas Capital Advisors LLC, based on Form 13F filings with the SEC.

Stay updated on Atlas Capital Advisors LLC with notifications on news.